ClinicalTrials.gg
RecruitingNCT05000645Updated Feb 17, 2026

Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women

An interventional study of Grocery delivery and Unsweetened beverage delivery in Pregnancy and Weight Gain, sponsored by University of Michigan. Recruiting at 1 site in United States. Open to female participants aged 14 Years to 26 Years. Per ClinicalTrials.gov, last updated 2026-02-17.

Sponsored by University of Michigan · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Dec 2021; still recruiting 4 years 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
570
Allocation
Randomized
Ages
14 Years to 26 Years
Sex
Female
01

Study summary

This project will increase knowledge about how a simple intervention, grocery delivery, impacts weight gain and diet among low-income pregnant young women. Results can then be used to support other pregnant young women.

Read the detailed description

The overall aim of this study is to determine whether an intervention that facilitates receipt of healthy food and unsweetened beverages will promote healthy weight gain and improve diet quality among pregnant young women age 14-26 living in Michigan. This hypothesis will be tested in a three-arm randomized controlled trial (RCT) using a parallel design; Arm 1: Usual WIC (Control), Arm 2: Usual WIC + Delivery of WIC-approved food, Arm 3: Usual WIC + Delivery of WIC-approved food PLUS unsweetened beverages. Three arms are necessary because our goal is to make three distinct comparisons. First, we need to determine the effect of food delivery (Arm 2) compared to usual WIC (Arm 1). Second, we need to determine the combined effect of food plus unsweetened beverage delivery (Arm 3) compared to usual WIC (Arm 1). Finally, we need to evaluate the effect of food delivery (Arm 2) compared with food plus unsweetened beverage delivery (Arm 3) to determine the individual impact of replacing SSBs, a major contributor to excessive pregnancy weight gain in our population. Our study does not assess the impact of delivering only unsweetened beverages compared to usual WIC because the potential policy implication is the delivery of WIC benefits. A widespread program that only delivers unsweetened beverages is not likely.

Upon completion of baseline screening and assessments, 570 pregnant young women will be randomly assigned to either the control group or one of the two experimental groups. Enrollment in the study is rolling and starts as early as possible in the pregnancy (must be before 21 weeks gestation). The intervention period begins at enrollment and continues to the end of pregnancy/birth. Thus, each participant will be enrolled for approximately seven months post-randomization. During the intervention period, all groups will receive usual WIC food, nutritional assessment, and counseling benefits, including monthly intensive nutritional counseling sessions based on a state-approved curriculum with trained nutritionists and peer counselors.

  • The control group (Arm 1) will receive usual WIC counseling and food benefits loaded onto their electronic benefits card (EBT) for them to use in person at approved grocery stores.
  • The first experimental group (Arm 2) will receive usual WIC counseling and food benefits, as well as twice-monthly home deliveries of WIC-approved foods.
  • The second experimental group (Arm 3) will receive usual WIC counseling and food benefits as well as twice-monthly home deliveries of WIC-approved foods PLUS unsweetened beverages to replace their current SSB intake.

The primary outcome is weight gain during pregnancy as defined by the Institute of Medicine (IOM)/National Academy of Medicine (NAM) Guidelines. Secondary outcomes include Healthy Eating Index (HEI) scores and dietary intake of fruits, vegetables, whole grains, and SSBs; infant birth weight; and prenatal and delivery complications identified through postpartum medical record review (e.g., small/large for gestational age, gestational diabetes, hypertensive disorders, operative delivery).

02

Conditions studied

  • Pregnancy
  • Weight Gain

Browse trials for

Keywords

  • WIC
  • Low-income
  • Diet
  • Sugar sweetened beverages
  • Grocery delivery
03

In context

Weight Gain

317 studies on the registry are indexed under Weight Gain; 48 are open to participants now.

This study's planned enrollment of 570 is above the median of 83 across 251 interventional studies indexed under Weight Gain.

Browse Weight Gain studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,506 studies on the registry; 192 are open to participants now.

Of its 169 completed or terminated interventional studies of FDA-regulated products, 133 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 26 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Gestational age ≤ 20 weeks
  • Text message capability
  • Healthy singleton pregnancy
  • Nulliparous
  • Consume sugar sweetened beverages (SSBs)
  • Living within delivery zone of a grocery delivery service

Exclusion criteria

Exclusion Criteria:

  • Non-English speaking
  • Participants who live at the same address
  • Physical, mental, or cognitive handicaps that prevent participation
  • High risk pregnancy requiring specialized care (including pre-existing diabetes)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
570 participants (estimated)

Study arms

  • No intervention
    Women, Infants, and Children (WIC)

    Usual WIC counseling and food benefits for use in person at approved grocery stores.

  • Experimental
    WIC + grocery delivery

    Usual WIC counseling and food benefits, as well as twice-monthly home deliveries of WIC-approved foods.

    Behavioral: Grocery delivery

  • Experimental
    WIC + grocery delivery + unsweetened beverage delivery

    Usual WIC counseling and food benefits as well as twice-monthly home deliveries of WIC-approved foods PLUS unsweetened beverages to replace their current sugar-sweetened beverages (SSB) intake.

    Behavioral: Grocery delivery · Behavioral: Unsweetened beverage delivery

Interventions

  • BehavioralGrocery delivery

    Each food delivery will contain approximately $35 worth of fresh fruits, vegetables, dairy products, and whole grain foods. These foods are not meant to supplant regular meals, rather make healthy eating more convenient.

  • BehavioralUnsweetened beverage delivery

    Participants will receive unsweetened beverages to replace normal sugar-sweetened beverage intake.

06

What researchers measure

Primary outcomes

  1. Weekly weight gain in pregnancy

    Frequency of weight categorizations, categorized as above, below, or within Institute of Medicine/National Academy of Medicine (IOM/NAM) guidelines, will be assessed. Data collected from BodyTrace scale and calculated as weight for a particular week minus pre-pregnancy weight.

    Time frame: Up to delivery, approximately 40 weeks

  2. Total weight gain in pregnancy

    Frequency of weight categorizations, categorized as above, below, or within Institute of Medicine/National Academy of Medicine (IOM/NAM) guidelines will be assessed. Data collected from BodyTrace scale and calculated as end of pregnancy weight minus pre-pregnancy weight.

    Time frame: At delivery, approximately 40 weeks

Secondary outcomes

  1. Dietary Quality as measured by the Healthy Eating Index (HEI) Score

    Dietary recall data collected via the ASA24 (Automated Self-Administered 24-Hour) Dietary Recall Survey will be used to determine continuous HEI scores. ASA24 data are collected twice at enrollment, twice in second trimester, and twice in third trimester and used in pairs to calculate 3 HEI scores per participant. The HEI uses a scoring system to evaluate a set of foods. The scores range from 0 to 100 with higher scores correlating to higher diet quality.

    Time frame: Up to delivery, approximately 40 weeks

  2. Occurrence of prenatal complications

    Frequency of prenatal complications will be assessed. Complications are collected from mother's medical record examples include gestational diabetes and hypertensive disorders.

    Time frame: Delivery, approximately 40 weeks

  3. Occurrence of delivery complications

    Frequency of delivery complications will be assessed. Complications are collected from mother's medical record and include operative delivery, shoulder dystocia, and postpartum hemorrhage.

    Time frame: Delivery, approximately 40 weeks

  4. Baby birth weight

    Collected from mother's medical record and will be categorized as small, appropriate, or large for gestational age based on weight percentiles (small \< 10th percentile, appropriate ≥ 10th percentile and ≤ 90th percentile, large \> 90th percentile).

    Time frame: Delivery, approximately 40 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Waselewski M, Plegue M, Sonneville K, Resnicow K, Ghumman A, Ebbeling C, Mahmoudi E, Sen A, Wolfson JA, Chang T. Grocery Delivery to Support Healthy Weight Gain Among Pregnant Young Women With Low Income: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2022 Aug 5;11(8):e40568. doi: 10.2196/40568. PubMed 35930351 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2021 (actual). Primary completion is estimated for Mar 2027, 62 months after the start.

Of 95 non-industry interventional studies with no phase under Weight Gain, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 62 months is above that.

Counting every sponsor, half of 101 studies reached it within 27 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 3, 2021
First posted
Aug 11, 2021
StartActual
Dec 8, 2021
Primary completionEst.
Mar 1, 2027
CompletionEst.
Apr 30, 2027
Last update
Feb 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05000645
Responsible party
Tammy Chang (Assistant Professor of Family Medicine, University of Michigan) — Principal investigator
First posted
Aug 11, 2021
Start date
Dec 8, 2021
Primary completion
Mar 1, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Feb 17, 2026

Study contacts

Marika Waselewski
Contact
marikag@umich.edu
734-237-3233
Tammy Chang, MD, MPH, MS
principal investigator · University of Michigan

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion